Comparison of an anticoagulation clinic with usual medical care: anticoagulation control, patient outcomes, and health care costs
E Chiquette, MG Amato, HI Bussey - Archives of internal …, 1998 - jamanetwork.com
Background The outcomes of an inception cohort of patients seen at an anticoagulation clinic
(AC) were published previously. The temporary closure of this clinic allowed the evaluation …
(AC) were published previously. The temporary closure of this clinic allowed the evaluation …
The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
J Ansell, J Hirsh, L Poller, H Bussey, A Jacobson… - Chest, 2004 - Elsevier
This article concerning the pharmacokinetics and pharmacodynamics of vitamin K antagonists
(VKAs) is part of the Seventh American College of Chest Physicians Conference on …
(VKAs) is part of the Seventh American College of Chest Physicians Conference on …
Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range
J Hirsh, JE Dalen, DR Anderson, L Poller, H Bussey… - Chest, 2001 - journal.chestnet.org
Abbreviations: AFASAK Atrial Fibrillation, Aspirin, Anticoagulation; AMI acute myocardial
infarction; AF atrial fibrillation; CARS Coumadin Aspirin Reinfarction Study; CI confidence …
infarction; AF atrial fibrillation; CARS Coumadin Aspirin Reinfarction Study; CI confidence …
Managing oral anticoagulant therapy
J Ansell, J Hirsh, J Dalen, H Bussey, D Anderson… - Chest, 2001 - journal.chestnet.org
Abbreviations: AMS anticoagulation management service; CV coefficient of variation; INR
international normalized ratio; IRP international reference preparation; ISI international …
international normalized ratio; IRP international reference preparation; ISI international …
Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range
J Hirsh, JE Dalen, DR Anderson, L Poller, H Bussey… - Chest, 1998 - journal.chestnet.org
T he optimal therapeutic range for oral. anticoagula~ t therapy was reviewed by the Comm1ttee
on Antithrombotic Therapy of the American College of Chest Physicians (ACCP) and the …
on Antithrombotic Therapy of the American College of Chest Physicians (ACCP) and the …
Antithrombotic therapy in valvular heart disease—native and prosthetic: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
DN Salem, PD Stein, A Al-Ahmad, HI Bussey… - Chest, 2004 - Elsevier
This chapter about antithrombotic therapy in native and prosthetic valvular heart disease is
part of the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy: …
part of the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy: …
Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves
PD Stein, JS Alpert, HI Bussey, JE Dalen, AGG Turpie - Chest, 2001 - journal.chestnet.org
In the present consensus report, we continue to address literature that may permit a more
refined assessment of the optimal level of the international normalized ratio (INR) for patients …
refined assessment of the optimal level of the international normalized ratio (INR) for patients …
Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range
J Hirsh, JE Dalen, D Deykin, L Poller, H Bussey - Chest, 1995 - journal.chestnet.org
The optimal therapeutic range for oral anticoagulant therapy was reviewed by the Committee
on Antithrombotic Therapy of the American College of Chest Physicians (ACCP) and the …
on Antithrombotic Therapy of the American College of Chest Physicians (ACCP) and the …
Effects of marine fish oils on the anticoagulation status of patients receiving chronic warfarin therapy
…, E Chiquette, WD Linn, GM Clark, HI Bussey - Journal of thrombosis …, 1998 - Springer
The purpose of this placebo-controlled, randomized, double-blinded, parallel study was to
determine the existence and magnitude of effect of various doses of fish oil supplements on …
determine the existence and magnitude of effect of various doses of fish oil supplements on …
A randomized trial of ascorbic acid in polyposis coli
HJR Bussey, JJ Decosse, EE Deschner, AA Eyers… - Cancer, 1982 - Wiley Online Library
The possibility of pharmacological control of large bowel adenomas has been suggested by
effectiveness of antioxidants in experimental tumor models and by the results of a limited …
effectiveness of antioxidants in experimental tumor models and by the results of a limited …